SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51753 $680.3 Million Worldwide CRISPR Technology Industry to 2027 Frank Sully-5/13/2021
51752From Vaccine to Drug Making, AstraZeneca is Relying on AI for Growth AstraZenecFrank Sully25/13/2021
51751I have much more confidence in Mark Eisner than I would have had with Peony at tJoe Wesley-5/11/2021
51750Roxadusdat has gone from 0 to 27% of the market and the greatest selling brand iA.J. Mullen15/11/2021
51749A re-stirring of Covid origin theories, thebulletin.org. It's a long read tA.J. Mullen15/10/2021
51748About Alphafold - An Awesome AI Invention That Will Change The Course of MedicinFrank Sully-5/7/2021
51747Chunky insider buys for microcap CYCN. fintel.ionigel bates-5/7/2021
51746With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market fFrank Sully-5/7/2021
51745Global CRISPR and CAS Gene Market to Surpass US$ 3,494.4 Million by 2027, Says CFrank Sully-5/6/2021
51744CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-EdiFrank Sully-5/6/2021
51743Global Ai In Pharma Market Report 2021: Long-term Forecast to 2025 & 2030 Frank Sully-5/6/2021
51742Fueled with a fresh half-billion dollars as AI investments boom, Exscientia is hFrank Sully-4/27/2021
51741CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates financeFrank Sully-4/27/2021
51740CRSP up 7% on news. CRISPR Therapeutics AG (CRSP) NasdaqGS - NasdaqGS Real TimeFrank Sully-4/26/2021
51739Crispr Therapeutics: Pipeline Catalyst Triggering Upside seekingalpha.comFrank Sully-4/23/2021
51738I'm sorry, you were correct. The Barron's article clearly says it'sA.J. Mullen-4/22/2021
51737Yup, CRSP is benefiting up-front and let VRTX hold majority of risk! They are noMiljenko Zuanic-4/22/2021
51736Crispr Therapeutics Is Upgraded After $900 Million Deal By Josh Nathan-Kazis Frank Sully-4/22/2021
51735It is indeed, but I don't believe it's new money. This about their origA.J. Mullen-4/20/2021
51734The biotech firm (VRTX) is paying $900 million to (CRSP) I think $900 million Frank Sully-4/20/2021
51733From inside the firewall, Vertex will now pay 60% of costs and and get 60% of thA.J. Mullen-4/20/2021
51732CRISPR Therapeutics: A Speculative Play On The Future Of Medicine seekingalpha.Frank Sully-4/20/2021
51731Vertex Is Buying Majority Rights to Gene-Editing Therapy From CRISPR TherapeuticFrank Sully-4/20/2021
51730The Bios continue to bleed in a good market. Some more bleeding followed by a paJamesK-4/12/2021
51729freakonomics.com ESRD market - - according to a Yale economist, " COOPER: software salesperson24/9/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News